Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 28.71

-2.4%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: max who wrote (1668)	4/4/1998 1:17:00 PM
From: JanyBlueEyes	Read Replies (1) of 5736

LED Device From the Annual Report (10K) Filed on March 30,1998 The Company has completed both the new housing and related packaging for its Colormate(TM) Bilirubin Device. The Company also recently completed development of the Bilirubin LED Device that could be used for monitoring bilirubin infant jaundice, subject to additional clinical testing and possible further FDA review and clearance. The Company recently received IRB approval from Mt. Sinai Hospital, Elmhurst Hospital and William Beaumont Hospital to commence clinical trials of the Bilirubin LED Device. For non-medical applications, the Colormate(TM) LED Device may be marketed in various industries including the dental, beauty aid and fashion industries and also may be marketed directly to consumers for home and personal use. The Company expects the new LED versions will also be capable of being manufactured at a cost substantially less than the cost incurred in manufacturing the Company's existing Colormate(TM) units.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next